These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy. Szymura SJ; Bernal GM; Wu L; Zhang Z; Crawley CD; Voce DJ; Campbell PA; Ranoa DE; Weichselbaum RR; Yamini B BMC Biol; 2020 Mar; 18(1):32. PubMed ID: 32209106 [TBL] [Abstract][Full Text] [Related]
7. FOXP3 gene expression in the blood of Iranian multiple sclerosis patients. Akbari Z; Taheri M; Jafari A; Sayad A Hum Antibodies; 2017; 26(3):159-164. PubMed ID: 29526847 [TBL] [Abstract][Full Text] [Related]
8. The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer. He C; Li A; Lai Q; Ding J; Yan Q; Liu S; Li Q Cell Death Dis; 2021 Jan; 12(1):74. PubMed ID: 33436563 [TBL] [Abstract][Full Text] [Related]
9. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. Xu Z; Li X; Li H; Nie C; Liu W; Li S; Liu Z; Wang W; Wang J Oncogene; 2020 Nov; 39(47):7051-7062. PubMed ID: 32989256 [TBL] [Abstract][Full Text] [Related]
10. FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis. Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sørensen PS Clin Exp Immunol; 2012 Nov; 170(2):149-55. PubMed ID: 23039885 [TBL] [Abstract][Full Text] [Related]
11. Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis. Tarighi M; Shahbazi M; Saadat P; Daraei A; Alizadeh Khatir A; Rahimifard K; Mohammadnia-Afrouzi M Int Immunopharmacol; 2023 Mar; 116():109797. PubMed ID: 36738680 [TBL] [Abstract][Full Text] [Related]
12. DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Mendonça VR; Souza LC; Garcia GC; Magalhães BM; Lacerda MV; Andrade BB; Gonçalves MS; Barral-Netto M Malar J; 2014 Jul; 13():278. PubMed ID: 25038626 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunity. Lepore MT; Bruzzaniti S; La Rocca C; Fusco C; Carbone F; Mottola M; Zuccarelli B; Lanzillo R; Brescia Morra V; Maniscalco GT; De Simone S; Procaccini C; Porcellini A; De Rosa V; Galgani M; Cassano S; Matarese G Sci Rep; 2024 Jul; 14(1):17571. PubMed ID: 39080325 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells. Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939 [TBL] [Abstract][Full Text] [Related]
16. UAP56/DDX39B is a major cotranscriptional RNA-DNA helicase that unwinds harmful R loops genome-wide. Pérez-Calero C; Bayona-Feliu A; Xue X; Barroso SI; Muñoz S; González-Basallote VM; Sung P; Aguilera A Genes Dev; 2020 Jul; 34(13-14):898-912. PubMed ID: 32439635 [TBL] [Abstract][Full Text] [Related]
17. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326 [TBL] [Abstract][Full Text] [Related]
18. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427 [TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M; Piccirillo CA J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [TBL] [Abstract][Full Text] [Related]
20. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses. Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]